Abstract
The benzodiazepine receptor antagonist 3-hydroxymethyl-β-carboline, which blocks several of the pharmacological actions of benzodiazepines, induces a dose-dependent increase in sleep latency in the rat. Furthermore, at a low dose that by itself does not affect sleep, 3-hydroxymethyl-β-carboline blocks sleep induction by a large dose of flurazepam. The benzodiazepine receptor may play a role in both the physiological regulation and pharmacological induction of sleep.
Original language | English |
---|---|
Pages (from-to) | 414-416 |
Number of pages | 3 |
Journal | Science |
Volume | 219 |
Issue number | 4583 |
DOIs | |
State | Published - 1983 |